Congratulations to Prof John Boldeman, former Director of the Australian Synchrotron Research Program, who this week became an Officer of the Order of Australia (AO), for his distinguished service to nuclear science and technology, particularly for his work in co-designing and overseeing the construction of the Australian Synchrotron.

Prof Boldeman played a lead role in proposing and promoting the Australian Synchrotron within government and the research community, as well as in the design of the facility.

 

 

Researchers from St Vincent’s Institute of Medical Research have used the Australian Synchrotron to reveal important new detail of the structure of a drug currently in advanced clinical trials to combat Alzheimer’s disease.

Alzheimer's peptide interacting with drug (SVI image)

An unusual and very exciting form of carbon - that can be created by drawing on paper - looks to hold the key to real-time, high throughput DNA sequencing, a technique that would revolutionise medical research and testing.

Graphene structure

Led by Dr Jiri Cervenka and PhD candidate Nikolai Dontschuk from the University of Melbourne, the study also included scientists from the Australian Synchrotron and La Trobe University and is published in Nature Communications.